PubMed:10415609
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 478-487 | protein | denotes | cytokines |
| T2 | 489-493 | protein | denotes | IL-2 |
| T3 | 495-499 | protein | denotes | IL-6 |
| T4 | 501-510 | protein | denotes | TNF-alpha |
| T5 | 512-517 | protein | denotes | IL-10 |
| T6 | 522-546 | cell_type | denotes | peripheral T lymphocytes |
| T7 | 585-590 | protein | denotes | NF-kB |
| T8 | 615-641 | cell_line | denotes | activated Jurkat cell line |
| T9 | 725-733 | protein | denotes | cytokine |
| T10 | 748-761 | cell_type | denotes | T lymphocytes |
| T11 | 816-821 | protein | denotes | NF-kB |
| T12 | 825-837 | cell_line | denotes | Jurkat cells |
| T13 | 865-874 | protein | denotes | cytokines |
| T14 | 999-1004 | protein | denotes | NF-kB |
| T15 | 1214-1234 | protein | denotes | transcription factor |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C23 | 54-96 | NP | denotes | different glucocorticoid hormone compounds |
| C1 | 98-137 | NP | denotes | Different glucocorticoid hormones (GCH) |
| C2 | 195-200 | NP | denotes | their |
| C3 | 258-261 | NP | denotes | GCH |
| C4 | 228-261 | NP | denotes | The mechanism(s) of action of GCH |
| C5 | 313-317 | NP | denotes | they |
| C6 | 396-412 | NP | denotes | prednisone (PDN) |
| C17 | 414-431 | NP | denotes | deflazacort (DFC) |
| C15 | 437-456 | NP | denotes | dexamethasone (DXM) |
| C18 | 396-456 | NP | denotes | prednisone (PDN), deflazacort (DFC), and dexamethasone (DXM) |
| C10 | 478-518 | NP | denotes | cytokines (IL-2, IL-6, TNF-alpha, IL-10) |
| C8 | 460-546 | NP | denotes | the production of cytokines (IL-2, IL-6, TNF-alpha, IL-10) by peripheral T lymphocytes |
| C7 | 671-694 | NP | denotes | the three GCH molecules |
| C9 | 725-761 | NP | denotes | cytokine production by T lymphocytes |
| C13 | 816-821 | NP | denotes | NF-kB |
| C11 | 857-887 | NP | denotes | all the cytokines investigated |
| C12 | 939-952 | NP | denotes | the three GCH |
| C16 | 961-964 | NP | denotes | DXM |
| C20 | 975-995 | NP | denotes | the binding activity |
| C14 | 999-1004 | NP | denotes | NF-kB |
| C19 | 1015-1019 | NP | denotes | that |
| C21 | 1023-1026 | NP | denotes | DFC |
| C22 | 1031-1034 | NP | denotes | PDN |
| C24 | 1086-1109 | NP | denotes | different GCH compounds |
| C25 | 1126-1131 | NP | denotes | their |
| R1 | C1 | C23 | coref-other | Different glucocorticoid hormones (GCH),different glucocorticoid hormone compounds |
| R2 | C2 | C1 | coref-pron | their,Different glucocorticoid hormones (GCH) |
| R3 | C3 | C1 | coref-ident | GCH,Different glucocorticoid hormones (GCH) |
| R4 | C5 | C4 | coref-pron | they,The mechanism(s) of action of GCH |
| R5 | C7 | C6 | coref-ident | the three GCH molecules,prednisone (PDN) |
| R6 | C9 | C8 | coref-ident | cytokine production by T lymphocytes,"the production of cytokines (IL-2, IL-6, TNF-alpha, IL-10) by peripheral T lymphocytes" |
| R7 | C11 | C10 | coref-ident | all the cytokines investigated,"cytokines (IL-2, IL-6, TNF-alpha, IL-10)" |
| R8 | C12 | C7 | coref-ident | the three GCH,the three GCH molecules |
| R9 | C16 | C15 | coref-ident | DXM,dexamethasone (DXM) |
| R10 | C14 | C13 | coref-ident | NF-kB,NF-kB |
| R11 | C19 | C20 | coref-pron | that,the binding activity |
| R12 | C21 | C17 | coref-ident | DFC,deflazacort (DFC) |
| R13 | C22 | C18 | coref-ident | PDN,"prednisone (PDN), deflazacort (DFC), and dexamethasone (DXM)" |
| R14 | C24 | C23 | coref-other | different GCH compounds,different glucocorticoid hormone compounds |
| R15 | C25 | C24 | coref-pron | their,different GCH compounds |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-97 | Sentence | denotes | Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds. |
| S2 | 98-227 | Sentence | denotes | Different glucocorticoid hormones (GCH) show differences in the intensity and in the kinetics of their immunomodulating activity. |
| S3 | 228-364 | Sentence | denotes | The mechanism(s) of action of GCH is under investigation, but is has been noted that they exert immune activity via the genomic pathway. |
| S4 | 365-642 | Sentence | denotes | We have studied the effects of prednisone (PDN), deflazacort (DFC), and dexamethasone (DXM) on the production of cytokines (IL-2, IL-6, TNF-alpha, IL-10) by peripheral T lymphocytes, and the effects on the inhibition of NF-kB DNA binding activity by activated Jurkat cell line. |
| S5 | 643-1035 | Sentence | denotes | The data obtained show that the three GCH molecules exert an immunosuppression on cytokine production by T lymphocytes and a strong decrease in the nuclear translocation of NF-kB in Jurkat cells; moreover, (a) not all the cytokines investigated were affected, and not with the same intensity, by the three GCH and (b) DXM inhibited the binding activity of NF-kB less than that of DFC and PDN. |
| S6 | 1036-1235 | Sentence | denotes | These data are in agreement with the concept that different GCH compounds might differ in their binding and affinity properties, tissue-specific metabolism, and interaction with transcription factor. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 64-96 | lipid | denotes | glucocorticoid hormone compounds |
| T2 | 108-133 | lipid | denotes | glucocorticoid hormones ( |
| T3 | 133-136 | lipid | denotes | GCH |
| T4 | 201-226 | other_name | denotes | immunomodulating activity |
| T5 | 258-261 | lipid | denotes | GCH |
| T6 | 324-339 | other_name | denotes | immune activity |
| T7 | 348-363 | other_name | denotes | genomic pathway |
| T8 | 396-408 | lipid | denotes | prednisone ( |
| T9 | 408-411 | lipid | denotes | PDN |
| T10 | 414-427 | lipid | denotes | deflazacort ( |
| T11 | 427-430 | lipid | denotes | DFC |
| T12 | 437-452 | lipid | denotes | dexamethasone ( |
| T13 | 452-455 | lipid | denotes | DXM |
| T14 | 478-487 | protein_family_or_group | denotes | cytokines |
| T15 | 489-493 | protein_molecule | denotes | IL-2 |
| T16 | 495-499 | protein_molecule | denotes | IL-6 |
| T17 | 501-510 | protein_molecule | denotes | TNF-alpha |
| T18 | 512-517 | protein_molecule | denotes | IL-10 |
| T19 | 522-546 | cell_type | denotes | peripheral T lymphocytes |
| T20 | 585-590 | protein_molecule | denotes | NF-kB |
| T21 | 615-641 | cell_line | denotes | activated Jurkat cell line |
| T22 | 681-684 | lipid | denotes | GCH |
| T23 | 704-721 | other_name | denotes | immunosuppression |
| T24 | 725-733 | protein_family_or_group | denotes | cytokine |
| T25 | 748-761 | cell_type | denotes | T lymphocytes |
| T26 | 791-812 | other_name | denotes | nuclear translocation |
| T27 | 816-821 | protein_molecule | denotes | NF-kB |
| T28 | 825-837 | cell_line | denotes | Jurkat cells |
| T29 | 865-874 | protein_family_or_group | denotes | cytokines |
| T30 | 949-952 | lipid | denotes | GCH |
| T31 | 961-964 | lipid | denotes | DXM |
| T32 | 979-995 | other_name | denotes | binding activity |
| T33 | 999-1004 | protein_molecule | denotes | NF-kB |
| T34 | 1023-1026 | lipid | denotes | DFC |
| T35 | 1031-1034 | lipid | denotes | PDN |
| T36 | 1096-1099 | lipid | denotes | GCH |
| T37 | 1132-1139 | other_name | denotes | binding |
| T38 | 1144-1163 | other_name | denotes | affinity properties |
| T39 | 1165-1191 | other_name | denotes | tissue-specific metabolism |
| T40 | 1214-1234 | protein_family_or_group | denotes | transcription factor |